Return to homepagePandemic Pact

Prognostication of ACE II Receptor (PACEiiR) [Funder: Genome BC]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Other Funders (Canada)

  • Principal Investigator

    Drs. Inna Sekirov, William Hsiao, Agatha Jassem, Natalie Prystajecky, Mel Krajden

  • Research Location

    Canada

  • Lead Research Institution

    University of British Columbia, BCCDC

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

A growing number of young and/or otherwise healthy COVID-19 patients are progressing to symptoms serious enough to require hospital admission and intubation for breathing assistance. This project aims to better understand how and why these patients become so unwell so quickly; this information will be critical to ensuring this growing patient population gets effective care. Researchers will study a large collection of viral samples, from the BC Centre for Disease Control, collected from patients' upper and lower respiratory tract, divided into study groups based on whether patients required hospital admission and breathing assistance. Genetic information from these samples will help the researchers identify biological markers of projected disease severity and progression. Future COVID-19 patients could then be tested for these same markers so that high risk patients can be quickly identified for targeted interventions.